News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • An Iran-linked strike damaged a fully loaded tanker at Dubai port, sparking a more than 3% jump in oil and shipping-risk concerns.
  • U.S. Trade Representative says WTO will play only a limited role after Cameroon deadlock; US will seek deals to preserve tariff-free digital transmissions.
  • RBA minutes show a narrow 5-4 vote to raise the cash rate 25bp to 4.1%, with future tightening uncertain due to Middle East risks.
  • The U.S. dollar posted its biggest monthly gain since July as Middle East tensions drove safe-haven flows and most currencies fell.
  • The yen steadied near 160 per dollar after Tokyo warned it may intervene if the currency weakens further.
  • Global bonds and gold have failed to attract shelter demand despite the conflict, leaving markets reliant on the dollar's uplift.

Latest Articles

European and Asian Equities Attract Heavy Flows as U.S. Stocks See Outflows

European and Asian Equities Attract Heavy Flows as U.S. Stocks See Outflows

In the week through February 11, global equity funds recorded a fifth consecutive weekly inflow of $25.54 billion, driven largely by substantial purchases of European and Asian equities. European funds logged $17.53 billion - the strongest weekly intake since at least 2022 - while Asian funds took in about $6.28 billion. U.S. equity funds experienc…

European Stocks Slip as AI Concerns and Mixed Results Cloud Markets

European Stocks Slip as AI Concerns and Mixed Results Cloud Markets

European equities fell on Friday as lingering worries over how new AI models may disrupt traditional business models weighed on sentiment. Mixed corporate reports from L’Oreal, Delivery Hero and Safran, together with disappointing gross margins at Cisco Systems, contributed to a cautious tone. The STOXX 600 was down about 0.3% and looked set to fin…

Stifel Affirms Buy on DexCom, Keeps $85 Price Target After Q4 Results

Stifel Affirms Buy on DexCom, Keeps $85 Price Target After Q4 Results

Stifel has reiterated a Buy rating on DexCom and maintained an $85.00 price target after the company’s fourth-quarter report, a level Stifel says is closely aligned with InvestingPro’s Fair Value assessment. The brokerage pointed to management’s upbeat commentary on sell-through trends that extended into early 2026, steady financial metrics and ups…

Sana Biotechnology: A high-risk, asymmetric swing trade on a biotech with a promising fusogen readout

Sana Biotechnology: A high-risk, asymmetric swing trade on a biotech with a promising fusogen readout

Sana (SANA) is a speculative long setup that pays to be small and patient. The company’s fusogen in vivo gene-editing work (published in Nature Biotechnology) is a real scientific milestone; the stock is cheap relative to upside if that program wins, but Sana faces cash burn, prior dilution and active litigation. Trade size accordingly and use a ha…

ConocoPhillips and partners to spend 20 billion kroner to revive Greater Ekofisk gas and condensate output

ConocoPhillips and partners to spend 20 billion kroner to revive Greater Ekofisk gas and condensate output

ConocoPhillips and its consortium will commit roughly 20 billion Norwegian crowns ($2.11 billion) to bring three fields in the Greater Ekofisk area back into production under the Previously Produced Fields (PPF) project. The plan targets gas and condensate recovery from Albuskjell, Vest Ekofisk and Tommeliten Gamma, which have been shut since 2019 …

Novartis Reports Vanrafia Slows Kidney Function Decline in Adults with IgAN

Novartis Reports Vanrafia Slows Kidney Function Decline in Adults with IgAN

Novartis reported that Vanrafia reduced the rate of kidney function decline in adults living with IgA nephropathy (IgAN) based on phase 3 trial results. The company previously received accelerated approvals in the United States and China in 2025 to treat proteinuria associated with IgAN, and intends to file for traditional regulatory approval in 20…

Huhtamaki posts modest Q4 beat, driven by strong cash generation

Huhtamaki posts modest Q4 beat, driven by strong cash generation

Huhtamaki reported a slight fourth-quarter earnings beat with EBIT of €103 million and earnings per share of €0.65, alongside a robust €311 million in free cash flow. Sales declined 2% year-on-year, with volume gains in North America and Fiber, while Foodservice sales fell amid weaker volumes in Western Europe and the UK. Management says trading co…

Ukraine Says IMF Board Sign-off on $8.2 Billion Programme Likely Within Weeks

Ukraine Says IMF Board Sign-off on $8.2 Billion Programme Likely Within Weeks

Ukraine's debt management chief says formal approval of an $8.2 billion International Monetary Fund programme should arrive imminently, a largely procedural but politically significant step as Kyiv navigates large fiscal gaps and wartime financial constraints. The deal is intended to replace a prior $15.6 billion facility and help sustain public ex…

U.S. Dispatches Second Carrier Strike Group to Middle East Amid Iran Standoff

U.S. Dispatches Second Carrier Strike Group to Middle East Amid Iran Standoff

U.S. media reported late Thursday that a second U.S. aircraft carrier - the USS Gerald R. Ford - along with its escort ships will be deployed from the Caribbean to the Middle East amid heightened tensions with Iran. The move follows earlier comments by President Donald Trump indicating he was considering a second carrier if negotiations with Iran f…

Policy Shifts in the West Bank Deepen Obstacles to a Two-State Outcome

Policy Shifts in the West Bank Deepen Obstacles to a Two-State Outcome

A set of recent Israeli decisions to streamline settler land purchases, repeal a Jordanian-era land law covering the West Bank, and expand monitoring and enforcement actions into territories with limited Palestinian self-rule has drawn sharp criticism from Palestinian leaders and raised fresh doubts about the viability of the two-state framework th…

Piper Sandler Lowers US Foods Rating to Neutral, Cites Rich Valuation

Piper Sandler Lowers US Foods Rating to Neutral, Cites Rich Valuation

Piper Sandler cut its rating on US Foods (NYSE:USFD) from Overweight to Neutral while increasing its price target to $103.00 from $85.00 after the company reported fourth-quarter fiscal 2025 results and updated fiscal 2026 guidance. The brokerage said the move reflects valuation pressures rather than a negative view of the company’s long-term prosp…